|
|
|
|
|
|
|
|
abstract
A
41-year-old woman receiving hemodialysis 3 times a week for chronic
kidney disease caused by interstitial nephritis was referred to our
hospital because of a pelvic mass and subsequently underwent primary
surgery . The patient was diagnosed with FIGO stage Ic(b)clear cell
adenocarcinoma. She did not receive postoperative chemotherapy. However,
9 months after surgery, ascites and a pelvic mass developed, on the
basis of which recurrence was confirmed. She received combination
chemotherapy with paclitaxel plus carboplatin(TC). Paclitaxel was
administered at 175mg/m2, and the carboplatin dosage was calculated by
the Calvert formula. The glomerular filtration rate was considered to be
0, and the target area under the plasma concentration versus time curve
was 5. Hemodialysis was performed 24 hours after the infusion of
carboplatin. After 6 courses of combination chemotherapy, complete
response was confirmed by computed tomography. The patient developed
grade 3 neutropenia, grade 1 sensory neuropathy , and grade 2 alopecia,
but the other adverse events were mild. In conclusion, TC combination
chemotherapy was well tolerated and generated a good response in a
patient with recurrent ovarian clear cell adenocarcinoma who was
receiving hemodialysis for chronic kidney disease.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.